CAMPAIGNS > CAMPAIGN FOR ACCESS TO MEDICINES

Radical reform of the medical R&D system

While TB kills around 1.5 million people per year, the entire world only invests around US$0.7bn on TB research every year — this is only a third of the US$2bn that the World Health Organisation estimates is needed.

TB is typical of a wider crisis of underinvestment by both pharmaceutical companies and governments in diseases mainly impacting poor people. TAC will continue to advocate for wider reforms to the medical innovation system that will incentivise more research and development based on global health needs (including new TB medicines and new antibiotics) through initiatives that avoid high prices at the end.